Anika Therapeutics Inc — Balance Sheet (NASDAQ:ANIK) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 365.61 M347.54 M349.13 M270.63 M202.74 M Total liabilities 93.56 M60.45 M63.56 M58.37 M48.75 M Total equity 272.4 M287.08 M285.56 M212.26 M153.99 M Total liabilities & shareholders' equities 365.61 M347.54 M349.13 M270.63 M202.74 M Total debt ————— Net debt —————

新闻

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika 2025年第四季度业绩:商业渠道激增抵消OEM业务下滑

Anika Q4 2025 slides: commercial surge offsets OEM decline

阿尼卡疗法有限公司Q4每股收益及营收超出预期

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics任命Stephen Griffin为新任首席执行官

Anika Therapeutics names Stephen Griffin as new CEO

安尼卡2025财年第三季度：商业渠道增长抵消OEM业务下滑

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika earnings beat by $0.22, revenue was in line with estimates